Working Capital

.Maris‑Tech Ltd. (Nasdaq: MTEK) issued $2 million in non‑interest‑bearing convertible promissory notes to institutional investors. Net proceeds will fund working capital, general corporate needs, and U.S. commercial expansion. Note A opens a conversion window at six months and is fully convertible at twelve months; Note B is fully convertible at twelve months, with any remaining principal automatically converting after twenty‑four months, all subject to a price‑floor formula. The notes were sold in a private placement exempt from registration, meaning they cannot be publicly resold and will dilute existing shareholders upon conversion.

Advanced Gold Exploration (CSE: AUEX) closed a non‑brokered private placement on Nov 27, 2025, issuing 5 million units at $0.05 each and raising $250,000. Each unit contains one common share and half a warrant exercisable at $0.065 per share for two years. Insiders subscribed for 2.8 million units; the company paid $8,500 cash and issued 170,000 shares as finder compensation. Proceeds will fund working capital, drilling and technology‑driven exploration. All securities are subject to a 4‑month‑plus‑1‑day hold period. Post‑placement, insider Arndt Roehlig holds ~19 % undiluted (≈26 % partially diluted).

Kane Biotech (TSX‑V: KNE) announced a non‑brokered private placement of up to 16 million common shares at $0.05 each, seeking up to $800,000 in gross proceeds. Funds will support working capital and general corporate needs, including its revyve® wound‑care platform. Insiders may participate. Closing is expected around December 17 2025, subject to TSX Venture Exchange approval, and all shares will be subject to a four‑month‑plus‑one‑day lock‑up. The offering is not registered in the United States and cannot be sold to U.S. persons.

Formation Metals (FOMTF) announced an upsized C$8.6M financing via LIFE units and a flow-through private placement to advance its N2 Gold Project in Quebec. The funding will increase working capital to ~$13M and the exploration budget to ~$8.5M+, supporting a 20,000-meter drill program. Phase 1, already underway, targets the “A” and “RJ” zones. The offering involves potential dilution and a hold period for flow-through shares. The N2 Gold Project boasts a historical resource of ~870,000 ounces with multiple zones open for expansion.

Revive Therapeutics (RVVTF) is extending its private placement to raise up to $650,000 by issuing units at $0.021 each. Each unit includes a share and a warrant exercisable at $0.05 for 36 months. Having already raised $60,900 in the first tranche, the remaining $589,000 will be used for working capital and settling trade payables. The securities are subject to a four-month and one-day hold period. While providing needed capital, the offering involves significant dilution potential for shareholders.

Silver Elephant Mining (SILEF) sold 3,000,000 Oracle Commodity Holding Corp shares on July 18th and 21st, 2025, generating $60,035. This reduces their stake in Oracle from 31.45% to 28.56% non-diluted (22.27% fully diluted). Proceeds will fund general operations. Silver Elephant retains the option to adjust its Oracle portfolio based on market conditions. They still holds 29,700,110 Oracle shares after the sale.

Permex Petroleum Corporation secured a US$2 million private placement of convertible debentures and warrants. The funds will bolster working capital for general operations and strategic initiatives. Each unit comprises a debenture with a 10% annual interest rate and common share purchase warrants. The financing is intended for accredited investors and closes after a five-day notice period.